VERU INC. Share-based Payment Arrangement, Expense, after Tax
VERU INC. (VERU) reported Share-based Payment Arrangement, Expense, after Tax of $796.45 thousand for the 12-month period ending 2011-09-30, per its 10-K filed 2011-12-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax · last filed 2011-12-02
- VERU INC. share-based payment arrangement, expense, after tax for fiscal 2011 was $796.45K, a 68.81% increase from fiscal 2010.
- VERU INC. share-based payment arrangement, expense, after tax for fiscal 2010 was $471.81K, a 26.23% increase from fiscal 2009.
- VERU INC. share-based payment arrangement, expense, after tax for fiscal 2009 was $373.78K.
| Period end | Share-based Payment Arrangement, Expense, after Tax 12 month |
|---|---|
| 2011-09-30 | $796.45K 10-K · filed 2011-12-02 |
| 2010-09-30 | $471.81K 10-K · filed 2011-12-02 |
| 2009-09-30 | $373.78K 10-K · filed 2011-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |